Evidence map›Paper›PMID 26316689›Full record

ReviewClinical ophthalmology (Auckland, N.Z.)2015

Noninfectious uveitis: strategies to optimize treatment compliance and adherence.

Rosa Dolz-Marco, Roberto Gallego-Pinazo, Manuel Díaz-Llopis, Emmett T Cunningham, J Fernando Arévalo

Open access · goldAbstract readReview
In one paragraph

Review in Clinical ophthalmology (Auckland, N.Z.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Outcomes of adalimumab therapy in refractory punctate inner choroidopathy and multifocal choroiditis.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Rosa Dolz-MarcoUnit of Macula, Department of Ophthalmology, University and Polytechnic Hospital La Fe, Spain.
Roberto Gallego-PinazoUnit of Macula, Department of Ophthalmology, University and Polytechnic Hospital La Fe, Spain.
Manuel Díaz-LlopisFaculty of Medicine, University of Valencia, Spain.
Emmett T CunninghamDepartment of Ophthalmology, California Pacific Medical Center, San Francisco, CA, USA ; Department of Ophthalmology, Stanford University School of Medicine, Stanford, CA, USA ; The Francis I Proctor Foundation, University of California San Francisco Medical Center, San Francisco, CA, USA ; West Coast Retina Medical Group, San Francisco, CA, USA.
J Fernando ArévaloVitreoretina Division, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia ; Retina Division, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Universitat de València · ESUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Noninfectious uveitis includes a heterogenous group of sight-threatening ocular and systemic disorders. Significant progress has been made in the treatment of noninfectious uveitis in recent years, particularly with regard to the effective use of corticosteroids and non-corticosteroid immunosuppressive drugs, including biologic agents. All of these therapeutic approaches are limited, however, by any given patient's ability to comply with and adhere to their prescribed treatment. In fact, compliance and adherence are among the most important patient-related determinants of treatment success. We discuss strategies to optimize compliance and adherence.

Indexed as

adherencecomplianceimmunosuppressive treatmentintraocular inflammationnoninfectious uveitistherapeutic failure

Identifiers

PMID26316689
PMCPMC4547652
OpenAlexW1734329965

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.